2010
DOI: 10.1016/j.jim.2010.02.001
|View full text |Cite
|
Sign up to set email alerts
|

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
57
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(57 citation statements)
references
References 10 publications
0
57
0
Order By: Relevance
“…To reformat the scFv fragments to whole, fully human IgG, the variable regions for both the heavy and kappa light chains of the rPfHRP2 specific scFv clones D2 and F9 were PCR amplified from the phagemid vectors and cloned into SacI-linearized ReformAb vectors (Acyte Biotech, Australia) as previously described [26]. …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…To reformat the scFv fragments to whole, fully human IgG, the variable regions for both the heavy and kappa light chains of the rPfHRP2 specific scFv clones D2 and F9 were PCR amplified from the phagemid vectors and cloned into SacI-linearized ReformAb vectors (Acyte Biotech, Australia) as previously described [26]. …”
Section: Methodsmentioning
confidence: 99%
“…The expression and purification of mAbs D2 and F9 was undertaken as previously described [26]. Briefly, the heavy and light chain plasmids were co-transfected into suspension-adapted Chinese hamster ovary (CHO) cells after mixing of plasmids with polyethylenimine (PEI).…”
Section: Methodsmentioning
confidence: 99%
“…Not all LIC methods are discussed in detail in this review, for example, the In-Fusion kit 6,31 which is a patent kit sold by Takara Bio Inc. (Dalian, China), and the nicking DNA endonuclease, in which the long sticky ends are created using a restriction enzyme Nt.BbvCI 32 . The readers can refer to the cited references for more information.…”
Section: Discussionmentioning
confidence: 99%
“…The variable regions of motavizumab and D25 antibodies were cloned and expressed in recombinant form. Briefly, the variable domains of the antibodies were cloned into separate plasmids encoding the heavy-and light-chain human IgG backbones described by Jones et al (37). Vectors were transfected into CHO cells in suspension culture, and supernatant was harvested 7 days later for secreted antibody, which was purified by protein A chromatography and buffer exchanged into PBS as previously described (38).…”
Section: Methodsmentioning
confidence: 99%